Back

Safety of hybrid epicardial–endocardial ablation in patients with persistent atrial fibrillation and heart failure with reduced left ventricular ejection fraction

30 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Optimising atrial fibrillation ablation pathways: safety, access, and same-day discharge Rhythm Control, Hybrid Therapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Omar Ahmed

St George's Hospital (London), London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Pulsed-field ablation for atrial fibrillation in patients with chronic kidney disease: acute safety and efficacy
Doctor S. Iida (JP)
Abstract
Presentation thumbnail
The feasibility of same-day discharge for the epicardial component of convergent hybrid ablation
Doctor O. Ahmed (London, GB)
Abstract
Presentation thumbnail
A dual-phase study of a bioabsorbable venous vascular closure system: identifying predictors of failure and ensuring long-term safety in over 1,000 procedures
Doctor T. Kanda (Osaka, JP)
Abstract
Presentation thumbnail
Comparison of VASCADE MVP XL and Figure of 8 suture for vascular closure of the Faradrive sheath for pulsed field ablation
Doctor T. Tanko (Gainesville, US)
Abstract
Presentation thumbnail
Same-day discharge after dual-energy ablation for atrial fibrillation
Doctor M. Lo (Little Rock, US)
Abstract

Access the full session

Session thumbnail
Optimising atrial fibrillation ablation pathways: safety, access, and same-day discharge

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
16-month outcomes following hybrid ablation for long-standing persistent atrial fibrillation in patients with dilated atria
28 August 2020
thumbnail
Congress Presentation
Is atrial fibrillation an independent predictor of mortality in patients with heart failure and a reduced left ventricular ejection fraction?
1 July 2021
thumbnail
Congress Presentation
Protected ventricular tachycardia ablation in severe LV dysfunction: acute safety and efficacy in the real world
14 April 2026
thumbnail
Congress Presentation
Safety and efficacy of pulmonary vein isolation during acute heart failure hospitalization
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources